Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta‐analysis from the GetGoal programme
Sign Up to like & getrecommendations! Published in 2017 at "Diabetes"
DOI: 10.1111/dom.12810
Abstract: To evaluate the long‐term efficacy and safety of lixisenatide, a short‐acting, prandial glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) as add‐on therapy in type 2 diabetes mellitus. read more here.
Keywords: type diabetes; diabetes mellitus; weeks treatment; effect lixisenatide ... See more keywords